|
|
||||||||


Departments of
*
Molecular Genetics, Biochemistry, and Microbiology, and
Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Cincinnati, Cincinnati, OH 45267
Surfactant protein A (SP-A) plays an important role in the innate immune defense of the respiratory tract. SP-A binds to lipid A of bacterial LPS, induces aggregation, destabilizes bacterial membranes, and promotes phagocytosis by neutrophils and macrophages. In this study, SP-A interaction with wild-type and mutant LPS of Bordetella pertussis, the causative agent of whooping cough, was examined. B. pertussis LPS has a branched core structure with a nonrepeating trisaccharide, rather than a long-chain repeating O-Ag. SP-A did not bind, aggregate, nor permeabilize wild-type B. pertussis. LPS mutants lacking even one of the sugars in the terminal trisaccharide were bound and aggregated by SP-A. SP-A enhanced phagocytosis by human monocytes of LPS mutants that were able to bind SP-A, but not wild-type bacteria. SP-A enhanced phagocytosis by human neutrophils of LPS-mutant strains, but only in the absence of functional adenylate cyclase toxin, a B. pertussis toxin that has been shown to depress neutrophil activity. We conclude that the LPS of wild-type B. pertussis shields the bacteria from SP-A-mediated clearance, possibly by sterically limiting access to the lipid A region.
This article has been cited by other articles:
![]() |
E. L. Westman, A. Preston, R. A. Field, and J. S. Lam Biosynthesis of a Rare Di-N-Acetylated Sugar in the Lipopolysaccharides of both Pseudomonas aeruginosa and Bordetella pertussis Occurs via an Identical Scheme despite Different Gene Clusters J. Bacteriol., September 15, 2008; 190(18): 6060 - 6069. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Giannoni, T. Sawa, L. Allen, J. Wiener-Kronish, and S. Hawgood Surfactant Proteins A and D Enhance Pulmonary Clearance of Pseudomonas aeruginosa Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 704 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Niedziela, I. Letowska, J. Lukasiewicz, M. Kaszowska, A. Czarnecka, L. Kenne, and C. Lugowski Epitope of the Vaccine-Type Bordetella pertussis Strain 186 Lipooligosaccharide and Antiendotoxin Activity of Antibodies Directed against the Terminal Pentasaccharide-Tetanus Toxoid Conjugate Infect. Immun., November 1, 2005; 73(11): 7381 - 7389. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Edwards, N. A. Groathouse, and S. Boitano Bordetella bronchiseptica Adherence to Cilia Is Mediated by Multiple Adhesin Factors and Blocked by Surfactant Protein A Infect. Immun., June 1, 2005; 73(6): 3618 - 3626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mattoo and J. D. Cherry Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies Clin. Microbiol. Rev., April 1, 2005; 18(2): 326 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Schaeffer, F. X. McCormack, H. Wu, and A. A. Weiss Interactions of Pulmonary Collectins with Bordetella bronchiseptica and Bordetella pertussis Lipopolysaccharide Elucidate the Structural Basis of Their Antimicrobial Activities Infect. Immun., December 1, 2004; 72(12): 7124 - 7130. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |